Psilocybin and Eugenol Reduce Inflammation in Human 3D EpiIntestinal Tissue
Life · 15.12.2023 · 13 (12) · 2345
DOI: 10.3390/life13122345 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life, online erschienen am 15.12.2023. Verfasst von Gregory Ian Robinson und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, University of Lethbridge, Lethbridge, AB T1K 3M4, Canada. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Mitacs, GoodCap Pharmaceuticals.
Abstract (Originalsprache)
Inflammation plays a pivotal role in the development and progression of inflammatory bowel disease (IBD), by contributing to tissue damage and exacerbating the immune response. The investigation of serotonin receptor 2A (5-HT2A) ligands and transient receptor potential (TRP) channel ligands is of significant interest due to their potential to modulate key inflammatory pathways, mitigate the pathological effects of inflammation, and offer new avenues for therapeutic interventions in IBD. This study investigates the anti-inflammatory effects of 5-HT2A ligands, including psilocybin, 4-AcO-DMT, and ketanserin, in combination with TRP channel ligands, including capsaicin, curcumin, and eugenol, on the inflammatory response induced by tumor necrosis factor (TNF)-α and interferon (IFN)-γ in human 3D EpiIntestinal tissue. Enzyme-linked immunosorbent assay was used to assess the expression of pro-inflammatory markers TNF-α, IFN-γ, IL-6, IL-8, MCP-1, and GM-CSF. Our results show that psilocybin, 4-AcO-DMT, and eugenol significantly reduce TNF-α and IFN-γ levels, while capsaicin and curcumin decrease these markers to a lesser extent. Psilocybin effectively lowers IL-6 and IL-8 levels, but curcumin, capsaicin, and 4-AcO-DMT have limited effects on these markers. In addition, psilocybin can significantly decrease MCP-1 and GM-CSF levels. While ketanserin lowers IL-6 and GM-CSF levels, there are no effects seen on TNF-α, IFN-γ, IL-8, or MCP-1. Although synergistic effects between 5-HT2A and TRP channel ligands are minimal in this study, the results provide further evidence of the anti-inflammatory effects of psilocybin and eugenol. Further research is needed to understand the mechanisms of action and the feasibility of using these compounds as anti-inflammatory therapies for conditions like IBD.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biological Sciences, University of Lethbridge, Lethbridge, AB T1K 3M4, Canada.
- GoodCap Pharmaceuticals, 520 3rd Avenue SW, Suite 1900, Calgary, AB T2P 0R3, Canada.
ORCID-Profile: Gregory Ian Robinson, Bo Wang, Marta Gerasymchuk, Igor Kovalchuk
Förderung
- Mitacs
- GoodCap Pharmaceuticals
Zitieren
APA
Robinson, G. I., Li, D., Wang, B., Rahman, T., Gerasymchuk, M., Hudson, D., Kovalchuk, O., & Kovalchuk, I. (2023). Psilocybin and Eugenol Reduce Inflammation in Human 3D EpiIntestinal Tissue. Life, 13(12), 2345. https://doi.org/10.3390/life13122345
Vancouver
Robinson GI, Li D, Wang B, Rahman T, Gerasymchuk M, Hudson D, et al. Psilocybin and Eugenol Reduce Inflammation in Human 3D EpiIntestinal Tissue. Life. 2023;13(12):2345. doi:10.3390/life13122345
BibTeX
@article{Robinson2023,
author = {Robinson, Gregory Ian and Li, Dongping and Wang, Bo and Rahman, Tahiat and Gerasymchuk, Marta and Hudson, Darryl and Kovalchuk, Olga and Kovalchuk, Igor},
title = {Psilocybin and Eugenol Reduce Inflammation in Human 3D EpiIntestinal Tissue},
journal = {Life},
year = {2023},
volume = {13},
number = {12},
pages = {2345},
doi = {10.3390/life13122345}
}
EUVIMED